Measurement uncertainty: Friend or foe?

Clinical laboratories rely on standardized measurement systems to ensure accurate patient results. However, gaps remain in how measurement uncertainty is communicated and applied. Prior research has shown that traceability to higher-order reference methods is essential for consistency. Yet, the uncertainty of each step in the traceability chain is often not fully transparent. No prior work has resolved how to effectively convey combined uncertainty from calibrators to end users. This uncertainty affects the reliability of clinical diagnostics. Without clear guidance, laboratories struggle to meet performance standards. The lack of accessible data on calibrators' traceability hinders quality control. This gap motivated the need to reframe measurement uncertainty as a quality indicator.

This study aims to clarify the role of measurement uncertainty in clinical diagnostics. It addresses the need for transparency in traceability and uncertainty estimation. The authors seek to highlight the limitations in current practices regarding calibrators. They emphasize the importance of reducing uncertainty in higher-order references. The study also explores how commercial measuring systems can improve precision. The goal is to shift the perception of uncertainty from a compliance metric to a quality measure. By analyzing traceability chains, the authors propose better communication strategies. This approach supports improved diagnostic accuracy and laboratory performance.

The authors reviewed existing literature on metrological traceability and measurement uncertainty. They examined how IVD manufacturers implement traceability in calibrators. The study analyzed the challenges in estimating and communicating combined uncertainty. It evaluated the impact of uncertainty on clinical sample measurements. The authors compared current practices with performance specifications. They assessed the role of higher-order reference materials in reducing uncertainty. The study also considered the precision of commercial measuring systems. The findings were synthesized to propose a new framework for uncertainty management.

The study found that traceability to higher-order references is critical for diagnostic accuracy. It revealed that uncertainty in calibrators is often not fully disclosed to end users. The authors identified a lack of standardized methods for estimating combined uncertainty. They noted that current practices fail to meet clinical performance requirements. The study showed that commercial systems need improved precision to reduce uncertainty. It emphasized that uncertainty should be a quality indicator, not just a compliance metric. The findings suggest that reducing uncertainty in higher-order references is essential. The authors concluded that better transparency and precision are needed in diagnostic systems.

The authors propose that measurement uncertainty should be treated as a quality indicator. They suggest that clinical laboratories need better access to calibrator traceability data. The study concludes that uncertainty must be managed throughout the traceability chain. It emphasizes the need for IVD manufacturers to improve transparency. The authors recommend that higher-order references be refined for lower uncertainty. They state that commercial measuring systems must increase precision. The study highlights the importance of aligning uncertainty with clinical performance. The authors argue that uncertainty should not be a compliance burden but a performance metric.